Big Science On resource constraints and merit In the face of complaints about how so few women have been
Bioinformatics The scientist as inadvertent loser Twice this week, I’d had occasion to write about how science
2019 nCoV Another controversy, another round of blaming preprints On February 1, Anand Ranganathan, the molecular biologist more popular as a
Chandrayaan 1 The virtues and vices of reestablishing contact with Vikram There was a PTI report yesterday that the Indian Space Research Organisation
Alibaba IPO Alibaba IPO – A vindication of China’s Internet? This is a guest post contributed by Anuj Srivas, tech. journalist and